| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INFINITUM ASSET MANAGEMENT, LLC | 9.9% | 0% | $90,602,588 | +$15,488,850 | 4,123,923 | +21% | INFINITUM ASSET MANAGEMENT, LLC | 31 Dec 2025 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 9.5% | $86,322,700 | 3,929,117 | Hillhouse Investment Management, Ltd. | 31 Dec 2025 | |||
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.9% | $75,183,720 | 3,412,788 | Suvretta Capital Management, LLC | 30 Jun 2025 | |||
| FMR LLC | 8.4% | $62,870,983 | 3,407,549 | FMR LLC | 30 Sep 2025 | |||
| ORBIMED ADVISORS LLC | 7.5% | $66,692,036 | 3,027,328 | ORBIMED ADVISORS LLC | 11 Aug 2025 | |||
| BlackRock, Inc. | 5.6% | +14% | $46,667,692 | +$6,277,844 | 2,319,341 | +16% | BlackRock, Inc. | 31 Dec 2025 |
| HBM Healthcare Investments (Cayman) Ltd. | 5.4% | $40,491,643 | 2,195,014 | HBM Healthcare Investments (Cayman) Ltd. | 08 Oct 2025 | |||
| Octagon Capital Advisors LP | 4.9% | $36,365,946 | 1,971,054 | Octagon Capital Advisors LP | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 4.5% | -9.6% | $37,611,688 | -$3,224,708 | 1,869,266 | -7.9% | The Vanguard Group | 31 Dec 2025 |
As of 31 Dec 2025, 118 institutional investors reported holding 40,095,319 shares of ArriVent BioPharma, Inc. - Common Stock (AVBP). This represents 96% of the company’s total 41,655,788 outstanding shares.
The largest institutional shareholders of ArriVent BioPharma, Inc. - Common Stock (AVBP) together control 89% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| INFINITUM ASSET MANAGEMENT, LLC | 9.9% | 4,123,923 | +6.6% | 12% | $82,973,331 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.9% | 4,106,035 | +11% | 2.1% | $82,613,424 |
| HHLR ADVISORS, LTD. | 9.4% | 3,929,117 | -12% | 2.5% | $79,053,834 |
| FMR LLC | 8.9% | 3,703,572 | +8.7% | 0% | $74,515,872 |
| ORBIMED ADVISORS LLC | 7.3% | 3,027,328 | 0% | 1.3% | $60,909,839 |
| BlackRock, Inc. | 5.7% | 2,372,838 | +16% | 0% | $47,741,500 |
| Octagon Capital Advisors LP | 4.7% | 1,971,054 | 0% | 5% | $39,657,606 |
| NOVO HOLDINGS A/S | 4.7% | 1,942,142 | 0% | 3% | $39,075,897 |
| VANGUARD GROUP INC | 4.5% | 1,869,266 | -7.9% | 0% | $37,609,632 |
| Sofinnova Investments, Inc. | 4.1% | 1,696,752 | 0% | 1.5% | $34,138,650 |
| General Catalyst Group Management, LLC | 3.6% | 1,494,786 | 0% | 14% | $30,075,094 |
| STATE STREET CORP | 2.6% | 1,091,980 | +6.3% | 0% | $21,970,638 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 753,519 | +5.2% | 0% | $15,164,192 |
| GOLDMAN SACHS GROUP INC | 1.8% | 742,526 | +72% | 0% | $14,939,623 |
| HSG Holding Ltd | 1.6% | 663,308 | 0% | 1% | $16,715,362 |
| AIHC Capital Management Ltd | 1.5% | 644,788 | 0% | 12% | $12,973,135 |
| Fund 1 Investments, LLC | 1.4% | 565,851 | -8.7% | 1.6% | $11,384,922 |
| CITADEL ADVISORS LLC | 1.1% | 458,502 | 0.01% | $9,225,060 | |
| UBS Group AG | 1.1% | 450,920 | -9.4% | 0% | $9,072,510 |
| MILLENNIUM MANAGEMENT LLC | 0.68% | 281,952 | -1.5% | 0% | $5,672,874 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.6% | 250,588 | +2.9% | 0% | $5,041,831 |
| NORTHERN TRUST CORP | 0.59% | 245,599 | +6.2% | 0% | $4,941,452 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.58% | 242,828 | 0.01% | $4,885,699 | |
| D. E. Shaw & Co., Inc. | 0.56% | 233,324 | 0% | $4,694,479 | |
| Point72 Asset Management, L.P. | 0.52% | 216,660 | 0.01% | $4,359,199 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 40,095,319 | $810,026,544 | +$20,808,260 | $20.12 | 118 |
| 2025 Q3 | 38,570,342 | $712,380,900 | +$89,390,869 | $18.45 | 104 |
| 2025 Q2 | 33,625,800 | $732,036,140 | +$99,572,817 | $21.77 | 96 |
| 2025 Q1 | 29,075,127 | $539,323,391 | +$6,162,682 | $18.49 | 82 |
| 2024 Q4 | 28,465,885 | $757,455,987 | +$26,598,551 | $26.64 | 80 |
| 2024 Q3 | 25,909,614 | $612,333,484 | +$70,385,573 | $23.50 | 68 |
| 2024 Q2 | 20,990,668 | $389,375,916 | -$3,300,286 | $18.55 | 53 |
| 2024 Q1 | 21,851,940 | $388,890,872 | +$388,416,714 | $17.86 | 53 |